Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $66.62M.
ENTERPRISE VALUE (EV)
$66.62M
Tiziana Life Sciences Ltd
Market Cap
$70.63M
Enterprise Value (EV)
$66.62M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Tiziana Life Sciences Ltd (TLSA) | $70.63M | $66.62M |
| Gain Therapeutics, Inc. (GANX)vs › | $71.23M | $58.76M |
| Champions Oncology, Inc. (CSBR)vs › | $69.61M | $76.22M |
| Verrica Pharmaceuticals Inc. (VRCA)vs › | $72.32M | $62.93M |
| Spero Therapeutics, Inc. (SPRO)vs › | $68.90M | $20.17M |
| MindWalk Holdings Corp. (HYFT)vs › | $72.83M | $69.88M |
| Fortress Biotech, Inc. (FBIO)vs › | $68.10M | N/A |
| Hyperfine, Inc. (HYPR)vs › | $73.27M | $43.22M |
| iBio, Inc. (IBIO)vs › | $67.52M | $13.33M |
| Pulmonx Corporation (LUNG)vs › | $75.18M | $75.55M |
Market Cap
$70.63M
Total Debt
$0.00
Cash
$4.01M
Enterprise Value
$66.62M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
